company-logo

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular and cerebrovascular drugs, digestive medicine, trauma injury medication, rehabilitation medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Guiyang, China.

GuiZhounLi Pharmaceutical Dividend Announcement

GuiZhounLi Pharmaceutical announced a annually dividend of ¥0.20 per ordinary share which will be made payable on 2024-06-17. Ex dividend date: 2024-06-17
GuiZhounLi Pharmaceutical annual dividend for 2024 was ¥0.20
GuiZhounLi Pharmaceutical annual dividend for 2023 was ¥0.10
GuiZhounLi Pharmaceutical's trailing twelve-month (TTM) dividend yield is 1.38%
GuiZhounLi Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 42.52%

GuiZhounLi Pharmaceutical Dividend History

Ex-Div dateDividend amountDividend typePay date
2024-06-17¥0.20annually2024-06-17
2023-06-01¥0.10annually2023-06-01
2021-06-07¥0.25annually2021-06-07

GuiZhounLi Pharmaceutical Dividend per year

GuiZhounLi Pharmaceutical Dividend Yield

GuiZhounLi Pharmaceutical current trailing twelve-month (TTM) dividend yield is 1.38%. Interested in purchasing GuiZhounLi Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:

GuiZhounLi Pharmaceutical Financial Ratios

P/E ratio18.01
PEG ratio3.05
P/B ratio3.70
ROE21.43%
Payout ratio42.52%
Current ratio1.99
Quick ratio1.62
Cash Ratio0.64

GuiZhounLi Pharmaceutical Dividend FAQ

Does GuiZhounLi Pharmaceutical stock pay dividends?
GuiZhounLi Pharmaceutical does not currently pay dividends to its shareholders.
Has GuiZhounLi Pharmaceutical ever paid a dividend?
No, GuiZhounLi Pharmaceutical has no a history of paying dividends to its shareholders. GuiZhounLi Pharmaceutical is not known for its dividend payments.
Why doesn't GuiZhounLi Pharmaceutical pay dividends?
There are several potential reasons why GuiZhounLi Pharmaceutical would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will GuiZhounLi Pharmaceutical ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While GuiZhounLi Pharmaceutical has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is GuiZhounLi Pharmaceutical a dividend aristocrat?
GuiZhounLi Pharmaceutical is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is GuiZhounLi Pharmaceutical a dividend king?
GuiZhounLi Pharmaceutical is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is GuiZhounLi Pharmaceutical a dividend stock?
No, GuiZhounLi Pharmaceutical is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy GuiZhounLi Pharmaceutical stocks?
To buy GuiZhounLi Pharmaceutical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy GuiZhounLi Pharmaceutical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.